Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about

< Previous 1 2 3 4 Next >
Biota Pharmaceuticals, Inc. Announces Name Change to Aviragen Therapeutics, Inc. (NASDAQ: AVIR)
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) today announced that the Company has changed its name to Aviragen Therapeutics, Inc., (“Aviragen Therapeutics”), a pharmaceutical company focused on the... 
From GlobeNewswire News Releases
Biota Initiates Phase 2a Efficacy Study of BTA585 for the Treatment of RSV Infections
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic... 
From GlobeNewswire News Releases
Biota Pharmaceuticals to Present at 15th Annual Needham Healthcare Conference
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic... 
From GlobeNewswire News Releases
Biota Pharmaceuticals Announces Sale of Antibiotic Assets to Spero Therapeutics
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) today announced that it has completed the sale of assets related to its broad spectrum antibiotic program to a newly formed subsidiary of Spero Therapeutics,... 
From GlobeNewswire News Releases
Biota Pharmaceuticals to Present at 28th Annual ROTH Conference
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the “Company”), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited... 
From GlobeNewswire News Releases
Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigations of Rockwell Medical, Inc., AAC Holdings, Inc., Dr. Reddy's Laboratories Ltd. and Biota Pharmaceuticals, Inc,; Encourages Inve
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential claims against Rockwell Medical, Inc., AAC Holdings, Inc., Dr. Reddy's Laboratories Ltd. and Biota Pharmaceuticals, Inc, as... 
From PR Newswire
Biota Announces Positive Results From Phase 1 Program for Direct Acting RSV Antiviral BTA585
Phase 2a RSV Challenge Study Planned for Q2 2016 
From GlobeNewswire News Releases
14 Biotechnology Stocks to Sell Now
 
Tags NASDAQ:ADMA NASDAQ:BOTA NASDAQ:SGMO
From InvestorPlace
Biota Receives FDA Fast Track Designation for Its Antiviral BTA585 for the Treatment of Respiratory Syncytial Virus Infections
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic... 
From GlobeNewswire News Releases
Biota Commences Dosing in Phase 2 Trial of Antiviral Therapy BTA074 for Topical Treatment of Condyloma
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic... 
From GlobeNewswire News Releases
Biota Pharmaceuticals Reports Second Quarter Fiscal Year 2016 Financial Results
Conference Call to be Held Today at 9:00 A.M. EST 
From GlobeNewswire News Releases
Biota Pharmaceuticals to Host Conference Call to Report Second Quarter Fiscal Year 2016 Financial Results on February 5, 2016
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the “Company”), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited... 
From GlobeNewswire News Releases
Stocks Hitting 52-Week Lows
Barracuda Networks Inc (NYSE: CUDA) shares touched a new 52-week low of $9.60. Guggenheim Securities downgraded Barracuda Networks ... 
Tags Benzinga CUDA News
From Benzinga
16 Biotechnology Stocks to Sell Now
 
Tags NASDAQ:CMRX NASDAQ:CNAT NASDAQ:NWBO
From InvestorPlace
Hottest Manufacturing Stocks Now – AETI HTBX DMTX GSI
 
Tags NYSE:GLF NASDAQ:CBPO NASDAQ:DMTX
From InvestorPlace
6 Biotechnology Stocks to Sell Now
 
Tags NASDAQ:AEGR Stocks to Sell NASDAQ:OVAS
From InvestorPlace
BioNap Consulting's Jason Napodano Interviewed by The Life Sciences Report
From Marketwired News Releases
Biota Announces Positive Phase 1 Data for Direct-Acting RSV Antiviral BTA585
Commences Dosing in Phase 1 Multiple Ascending Dose Study with Top-Line Data Expected in 1H 2016 
From GlobeNewswire News Releases
Biggest Movers in Manufacturing Stocks Now – ADXS ARRY CBYL OVAS
 
Tags NASDAQ:ARRY NASDAQ:TROV NYSE:QUAD
From InvestorPlace
Biota Pharmaceuticals to Participate in the Guggenheim Securities 3rd Annual Boston Healthcare Conference
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic... 
From GlobeNewswire News Releases
Hottest Manufacturing Stocks Now – GAI IDRA BNTC BOTA
 
Tags NASDAQ:ATRA NASDAQ:EFOI Hot Stocks
From InvestorPlace
Equites On the Move- Research on Aware, Biota Pharmaceuticals, Aldeyra Therapeutics and Northern Technologies
Tags Business & Professional Services
From ACCESSWIRE
13 Biotechnology Stocks to Sell Now
 
Tags NASDAQ:SGMO NASDAQ:BOTA NASDAQ:AGIO
From InvestorPlace
Biota Pharmaceuticals to Present at Stifel 2015 Healthcare Conference
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited... 
From GlobeNewswire News Releases
Biota Pharmaceuticals Reports First Quarter Fiscal Year 2016 Financial Results
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals to treat infections that have limited therapeutic options,... 
From GlobeNewswire News Releases
Biota Pharmaceuticals Announces Appointment of Mark P. Colonnese as Chief Financial Officer
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic... 
From GlobeNewswire News Releases
16 Biotechnology Stocks to Sell Now
 
Tags NASDAQ:OREX NASDAQ:ALNY NASDAQ:BOTA
From InvestorPlace
Biota Pharmaceuticals to Host Conference Call to Report First Quarter Fiscal Year 2016 Financial Results on November 6, 2015
Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited... 
From GlobeNewswire News Releases
BIOTA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues Investigation of Biota Pharmaceuticals, Inc.; Investors Encouraged to Contact the Firm
BIOTA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues Investigation of Biota Pharmaceuticals, Inc.; Investors Encouraged to Contact the Firm 
From Business Wire News Releases
Biota Pharmaceuticals to Present at Ladenburg Thalmann 2015 Healthcare Conference
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited... 
From GlobeNewswire News Releases
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.